However, when it comes to sophisticated medications like tirzepatide, the date on the label is more than just a suggestion

Effects of Low-Dose, Controlled-Release, Phentermine Plus Topiramate Combination on Weight and Associated Comorbidities in Overweight and Obese Adults (CONQUER): A Randomised, Placebo-Controlled, Phase 3 Trial (April 16, 2011) TOPAMAX (topiramate) TABLETS, for oral use product label (1996) Topiramate (Topamax): Evolving Role in Weight Reduction Management: A Narrative Review (August 31, 2023) Efficacy and Safety of Topiramate in Binge Eating Disorder: A Systematic Review and Meta-analysis (July 9, 2020) Brief Communication: Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and Appetite (December 7, 2004) Effects of Chronic Social Stress on Obesity (January 11, 2012) Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association (October 11, 2016) Severity of Topiramate-Related Working Memory Impairment Is Modulated by Plasma Concentration and Working Memory Capacity (April 16, 2020) Clinical Utility Of Phentermine/Topiramate (Qsymia) Combination For The Treatment Of Obesity (April 08, 2013) Once-Weekly Semaglutide in Adults With Overweight or Obesity (February 10, 2021) Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022) OZEMPIC (semaglutide) injection, for subcutaneous use

Both tirzepatide and semaglutide treatment led to similar improvements in fasted and postprandial appetite-related sensations (Table S1) and reduction of food intake at an ad libitum meal (348.4 kcal and 284.1 kcal, respectively
Additionally, this eating method can also promote cognition